Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Panacea Biotec Ltd. Share Price
Day's Range
Low
₹362.05
High
₹380.00
Price Summary
| Previous Close | ₹375.25 |
|---|---|
| Day's Range | ₹362.05 - ₹380.00 |
| Open | ₹366.45 |
| 52 Week Range | ₹292.40 - ₹647.00 |
| Volume | 64,320 |
| Market Cap | ₹0.00 |
| Previous Close | ₹375.90 |
|---|---|
| Day's Range | ₹360.85 - ₹379.50 |
| Open | ₹366.30 |
| 52 Week Range | ₹293.10 - ₹647.50 |
| Volume | 4,530 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 241.36 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 0.00 |
| TTM EPS (₹) | -1.16 |
| P/E Ratio | 0.00 |
| Book Value(₹) | 2.69 |
| PAT Margin (%) | -1.10 |
| Face Value (₹) | 1.00 |
| ROCE(%) | -0.15 |
| Trade Value ( ₹ in Lacs) | 17.03 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 0.00 |
| TTM EPS (₹) | -1.16 |
| P/E Ratio | 0.00 |
| Book Value(₹) | 2.69 |
| PAT Margin (%) | -1.10 |
| Face Value (₹) | 1.00 |
| ROCE(%) | -0.15 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 1122.5 | 3098.5 |
| Expenses | N/A | N/A |
| PBT | -88.4 | -260.6 |
| Operating profit | 0.0 | 0.0 |
| Net profit | -67.0 | -152.3 |
About Panacea Biotec Ltd.
| Founded | 1984 |
|---|---|
| Managing Director | Rajesh Jain |
| NSE Symbol | PANACEABIO |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,41,477.63 | 1,860.00 | 1,580.00 - 1,580.00 |
| Divi's Laboratories Ltd. | 2,53,031.38 | 9,475.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,85,216.32 | 4,915.15 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,27,421.96 | 8,701.90 | 6,696.50 - 6,696.50 |
| Zydus Lifesciences Ltd. | 1,20,897.46 | 1,195.20 | 835.50 - 835.50 |
| Lenskart Solutions Ltd. | 1,14,028.91 | 673.95 | 0.00 - 0.00 |
| Cipla Ltd. | 1,12,205.15 | 1,383.00 | 1,165.70 - 1,165.70 |
| Laurus Labs Ltd. | 1,08,710.82 | 1,985.60 | 826.20 - 826.20 |
| Dr. Reddy's Laboratories Ltd. | 1,02,039.66 | 1,250.00 | 1,101.00 - 1,101.00 |
| Mankind Pharma Ltd. | 1,00,764.41 | 2,545.00 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Panacea Biotec informs about details of shares dematerialized
With reference to CDSL’s Operating Instructions for Issuers / RTAs, which states that the Issuer / RTA shall inform the details of the securities dematerialized to all the Stock Exchanges where the securities are listed. Accordingly, Panacea Biotec has informed that no share has been dematerialized during the month of July 2026. The company has confirmed that the total number of shares dematerialized as on July 31, 2026, were as under: NSDL 5,26,65,454 CDSL 84,40,072 Total 6,11,05,526 A copy of the certificate obtained from the Company’s RTA - Skyline Financial Services, regarding shares dematerialized as on July 31, 2026, is also enclosed as Annexure -1.
The above information is a part of company’s filings submitted to BSE.
Panacea Biotec informs about disclosure
Family Care Hospitals informs about SAST
Decipher Labs informs about closure of trading window
Pursuant to the Code of Conduct for Prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, Decipher Labs has informed that the trading window for dealing in the securities of the Company will remain closed from 01.10.2026 till 48 hours after the declaration of un audited financial results for the quarter and half year ending 30.09.2026, for all designated persons, their immediate relatives and all connected persons covered under the Company’s Code of Conduct. The same has been intimated to all the directors, officers and designated employees of the Company. Further the date of Board Meeting for the declaration of financial results of the Company for the quarter and half year ending 30.09.2026 will be intimated in due course.
Aarti Pharmalabs informs about closure of trading window
Pursuant to Company’s Code Prohibition of Insider Trading framed pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and amendments thereunder, Aarti Pharmalabs has informed that the trading window for dealing in the securities of the Company will remain closed from Thursday, October 01, 2026 till 48 hours after the declaration of Financial Results of the Company for the quarter ending on September 30, 2026. The same has also been intimated to all the Designated Persons/Connected Persons of the Company. The date of the Board Meeting in which the said results will be considered for approval, will be informed in due course.
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Panacea Biotec Ltd. is ₹375.25 as of 2026-09-29.
The market capitalisation of Panacea Biotec Ltd. is ₹2,252.50 as of 2026-09-28.
The 1-year return of Panacea Biotec Ltd. is -29.40% as of 2026-09-29.
The P/E ratio of Panacea Biotec Ltd. is 0.00 as of 2026-09-29.
The 52-week high and low of Panacea Biotec Ltd. are ₹647.00 and ₹292.40, respectively, as of 2026-09-29.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
